Joint Formulary & PAD

Interferon beta - Multiple sclerosis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intramuscular injection (IM)
  • Subcutaneous injection (sc)
Associated Icons :
NHSE
NICE
SPC
Restrictions / Comments :
Important

Interferon beta 1a (Avonex, Rebif)

 

Status 2

Red
Formulations :
  • Subcutaneous injection (sc)
Associated Icons :
NHSE
NICE
SPC
Restrictions / Comments :
Important

Interferon beta 1b (Betaferon, Extavia)

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Interferon beta
Indication :
Multiple sclerosis
Group Name :
Keywords :
MS, relapsing-remitting multiple sclerosis
Brand Names Include :
Betaferon, Avonex, Rebif, Extavia
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Interferon beta is used to treat.

  • No records returned.

Committee Recommendations (1)

01 Apr 13 - Not Set
This drug / device falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.
Treatment should remain with the specialist (RED) hospital only drug.

GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.